• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估与老年美国医疗保险受益人药物费用相关不依从相关因素的重要性。

Assessing the Importance of Factors Associated with Cost-Related Nonadherence to Medication for Older US Medicare Beneficiaries.

机构信息

Department of Health Services Research, The University of Texas MD Anderson Cancer Center, 1400 Pressler St., Unit 1444, Houston, TX, 77030, USA.

Division of Outcomes Research and Quality, Department of Surgery, College of Medicine, Penn State University, Hershey, PA, USA.

出版信息

Drugs Aging. 2019 Dec;36(12):1111-1121. doi: 10.1007/s40266-019-00715-3.

DOI:10.1007/s40266-019-00715-3
PMID:31686403
Abstract

BACKGROUND

Prescription drug costs have been rising rapidly in the USA, contributing to the persistent problem of cost-related medication nonadherence (CRN) among older Medicare beneficiaries. Given the importance of CRN and the negative outcomes associated with it, it is important to examine the factors that affect CRN. This study aims to estimate the factors influencing CRN among older Medicare beneficiaries and to rank their relative contribution in explaining CRN.

METHODS

We used a 2015 Medicare Current Beneficiary Survey linked to Medicare claims data to identify older Medicare beneficiaries aged 65 years and over. Multivariate logistic regression was performed to identify factors associated with CRN. Factors included in the regression analyses were based on a conceptual framework adapted from Piette et al., including main effects (financial factors and regimen complexity) and contextual factors (sociodemographic, lifestyle and health factors). Dominance analysis was conducted to determine their relative importance in predicting CRN.

RESULTS

Our study sample included 4427 older Medicare beneficiaries, 13.43% of whom reported CRN. For main effects, drug coverage and regimen complexity were significantly associated with CRN. Compared to beneficiaries with public coverage, those with private drug coverage were less likely to report CRN while those without drug coverage were more likely to report CRN. Having more than two monthly prescriptions was also associated with higher CRN. Significant contextual factors included age, activities of daily living limitations, perceived health status, cancer, rheumatoid arthritis, non-rheumatoid arthritis, depression, and lung disease. Dominance analysis showed drug coverage was the most influential factor in explaining CRN, after which age, ADL limitations, and depression ranked in sequence.

CONCLUSIONS

These findings can help policy makers understand the relative importance of factors affecting CRN and identify the most important areas for intervention to improve CRN.

摘要

背景

在美国,处方药费用迅速上涨,导致老年医疗保险受益人持续存在与费用相关的药物不依从(CRN)问题。鉴于 CRN 的重要性及其相关的负面后果,研究影响 CRN 的因素非常重要。本研究旨在估计影响老年医疗保险受益人的 CRN 的因素,并对其解释 CRN 的相对贡献进行排名。

方法

我们使用 2015 年医疗保险当前受益人调查与医疗保险索赔数据相关联,以确定 65 岁及以上的老年医疗保险受益人。采用多变量逻辑回归来确定与 CRN 相关的因素。回归分析中包含的因素基于 Piette 等人的概念框架,包括主要效应(财务因素和方案复杂性)和情境因素(社会人口统计学、生活方式和健康因素)。进行优势分析以确定它们在预测 CRN 方面的相对重要性。

结果

我们的研究样本包括 4427 名老年医疗保险受益人,其中 13.43%报告存在 CRN。对于主要效应,药物覆盖范围和方案复杂性与 CRN 显著相关。与具有公共覆盖范围的受益人相比,具有私人药物覆盖范围的受益人报告 CRN 的可能性较小,而没有药物覆盖范围的受益人报告 CRN 的可能性较大。每月有超过两种处方也与更高的 CRN 相关。显著的情境因素包括年龄、日常生活活动受限、感知健康状况、癌症、类风湿性关节炎、非类风湿性关节炎、抑郁和肺部疾病。优势分析显示,药物覆盖范围是解释 CRN 的最具影响力的因素,其次是年龄、ADL 限制和抑郁。

结论

这些发现可以帮助政策制定者了解影响 CRN 的因素的相对重要性,并确定改善 CRN 的最重要干预领域。

相似文献

1
Assessing the Importance of Factors Associated with Cost-Related Nonadherence to Medication for Older US Medicare Beneficiaries.评估与老年美国医疗保险受益人药物费用相关不依从相关因素的重要性。
Drugs Aging. 2019 Dec;36(12):1111-1121. doi: 10.1007/s40266-019-00715-3.
2
Prevalence and Persistence of Cost-Related Medication Nonadherence Among Medicare Beneficiaries at High Risk of Hospitalization.住院高风险医疗保险受益人中与费用相关的药物治疗不依从的患病率和持续性
JAMA Netw Open. 2021 Mar 1;4(3):e210498. doi: 10.1001/jamanetworkopen.2021.0498.
3
Cost-related medication nonadherence among Medicare beneficiaries with cardiovascular disease risk factors: The role of comprehension of the Medicare programme and its prescription drug benefits.患有心血管疾病风险因素的医疗保险受益人中与费用相关的药物治疗不依从性:对医疗保险计划及其处方药福利的理解所起的作用。
J Eval Clin Pract. 2023 Feb;29(1):136-145. doi: 10.1111/jep.13745. Epub 2022 Aug 18.
4
Cost-related Medication Nonadherence and Its Risk Factors Among Medicare Beneficiaries.医疗保险受益人群中与费用相关的药物不依从及其风险因素。
Med Care. 2021 Jan;59(1):13-21. doi: 10.1097/MLR.0000000000001458.
5
Cost-related medication nonadherence and cost-saving strategies used by elderly Medicare cancer survivors.老年人 Medicare 癌症幸存者的与费用相关的药物不依从和节省费用策略。
J Cancer Surviv. 2011 Dec;5(4):395-404. doi: 10.1007/s11764-011-0188-4. Epub 2011 Jul 29.
6
Depression and cost-related medication nonadherence in Medicare beneficiaries.医疗保险受益人的抑郁症与药物费用相关的治疗依从性不佳问题。
Arch Gen Psychiatry. 2007 May;64(5):602-8. doi: 10.1001/archpsyc.64.5.602.
7
Prescription drug coverage satisfaction, cost-reducing behavior, and medication nonadherence among Medicare beneficiaries with type 2 diabetes.医疗保险受益的 2 型糖尿病患者的处方药覆盖满意度、降低成本行为和药物不依从性。
J Manag Care Spec Pharm. 2021 Jun;27(6):696-705. doi: 10.18553/jmcp.2021.27.6.696.
8
Cost-related medication nonadherence in older patients with rheumatoid arthritis.老年类风湿关节炎患者与费用相关的药物不依从。
J Rheumatol. 2013 Feb;40(2):137-43. doi: 10.3899/jrheum.120441. Epub 2013 Jan 15.
9
Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.医疗保险D部分实施后与费用相关的药物治疗不依从性及基本需求支出
JAMA. 2008 Apr 23;299(16):1922-8. doi: 10.1001/jama.299.16.1922.
10
Persistent medication affordability problems among disabled Medicare beneficiaries after Part D, 2006-2011.2006年至2011年,医疗保险D部分实施后,残疾医疗保险受益人的药物可负担性问题持续存在。
Med Care. 2014 Nov;52(11):951-6. doi: 10.1097/MLR.0000000000000205.

引用本文的文献

1
Geospatial distribution of the adoption of dipeptidyl-peptidase-4 inhibitors for type 2 diabetes among Medicare beneficiaries.医疗保险受益人中2型糖尿病患者使用二肽基肽酶-4抑制剂的地理空间分布情况。
Spat Spatiotemporal Epidemiol. 2025 Feb;52:100711. doi: 10.1016/j.sste.2025.100711. Epub 2025 Jan 10.
2
An adapted model of cost-related medication nonadherence among older adult patients with chronic diseases: an Iranian qualitative study.慢性病老年患者中与费用相关的药物不依从的适应模型:伊朗定性研究。
BMC Geriatr. 2023 Apr 1;23(1):208. doi: 10.1186/s12877-023-03907-0.
3
The Association Between Cost-Related Non-Adherence Behaviors and Diabetes Outcomes.

本文引用的文献

1
Cost-related medication non-adherence among U.S. adults with diabetes.美国糖尿病患者的药物费用相关不依从性。
Diabetes Res Clin Pract. 2018 Sep;143:24-33. doi: 10.1016/j.diabres.2018.06.016. Epub 2018 Jun 23.
2
Financial toxicity and implications for cancer care in the era of molecular and immune therapies.分子和免疫治疗时代的经济毒性及其对癌症治疗的影响。
Ann Transl Med. 2018 May;6(9):166. doi: 10.21037/atm.2018.03.28.
3
National trends in prescription drug expenditures and projections for 2018.2018年处方药支出的全国趋势及预测。
与费用相关的不依从行为与糖尿病结局的关系。
J Am Board Fam Med. 2023 Feb 8;36(1):15-24. doi: 10.3122/jabfm.2022.220272R2.
4
Building Community-Engaged Multidisciplinary Partnerships to Improve Medication Management in Elderly Patients With Multiple Chronic Conditions.建立社区参与的多学科伙伴关系以改善患有多种慢性病的老年患者的药物管理。
J Patient Cent Res Rev. 2021 Apr 19;8(2):113-120. eCollection 2021 Spring.
5
Social capital and cost-related medication nonadherence (CRN): A retrospective longitudinal cohort study using the Health and Retirement Study data, 2006-2016.社会资本与药物费用相关的治疗依从性差(CRN):一项使用2006 - 2016年健康与退休研究数据的回顾性纵向队列研究。
SSM Popul Health. 2020 Oct 5;12:100671. doi: 10.1016/j.ssmph.2020.100671. eCollection 2020 Dec.
Am J Health Syst Pharm. 2018 Jul 15;75(14):1023-1038. doi: 10.2146/ajhp180138. Epub 2018 May 10.
4
Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium.老年人的多种疾病与多重用药:第三个千年内科医生面临的挑战
J Comorb. 2011 Dec 27;1:28-44. doi: 10.15256/joc.2011.1.4. eCollection 2011.
5
Financial Toxicity and Societal Costs of Cancer Care: Distinct Problems Require Distinct Solutions.癌症治疗的财务毒性和社会成本:不同的问题需要不同的解决方案。
Oncologist. 2017 Feb;22(2):123-125. doi: 10.1634/theoncologist.2016-0301. Epub 2017 Feb 6.
6
The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.美国处方药价格居高不下:根源与改革前景。
JAMA. 2016;316(8):858-71. doi: 10.1001/jama.2016.11237.
7
How payment scheme affects patients' adherence to medications? A systematic review.支付方案如何影响患者的药物依从性?一项系统综述。
Patient Prefer Adherence. 2016 May 13;10:837-50. doi: 10.2147/PPA.S103057. eCollection 2016.
8
Risk factors for cost-related medication non-adherence among older patients with cancer.老年癌症患者中与费用相关的药物治疗不依从的风险因素。
Integr Cancer Sci Ther. 2015 Dec;2(6):300-304. Epub 2015 Nov 6.
9
Cost-Related Medication Nonadherence and Cost-Saving Behaviors Among Patients With Glaucoma Before and After the Implementation of Medicare Part D.医疗保险D部分实施前后青光眼患者与费用相关的药物治疗不依从性和节省费用行为
JAMA Ophthalmol. 2015 Sep;133(9):985-96. doi: 10.1001/jamaophthalmol.2015.1671.
10
Construct validity and factor structure of survey-based assessment of cost-related medication burden.基于调查的与费用相关的药物负担评估的结构效度和因子结构
Med Care. 2015 Feb;53(2):199-206. doi: 10.1097/MLR.0000000000000286.